Skip to main content
CRSP logo

CRSP · CRISPR Therapeutics AG · Debt

Track CRSP — free
$49.39 -0.60 (-1.20%) At close · Oct 23
Market Cap
$4.78B
Shares
96.69M
Volume · Oct 23 2.12M Avg daily vol (3M) 1.56M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 18,646,000 10-Q filed 2026-08-03
Long-term debt, including current maturities 2026-06-30 USD 586,198,000 10-Q filed 2026-08-03
Noncurrent operating lease liabilities 2026-06-30 USD 178,904,000 10-Q filed 2026-08-03
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1674416 CUSIP H17182108 13F (30d) 89 filings 89 filers Visit website Investor relations